A major discovery in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant inhibitor protein is frequently disabled in many forms of tumors, leading uncontrolled body https://indexedbookmarks.com/story21849193/nanobodies-reactivate-the-p53-protein-a-new-hope-for-malignant-therapy